Fennec Pharmaceuticals Inc
F:RV41
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fennec Pharmaceuticals Inc
F:RV41
|
US |
|
I
|
Iss A/S
XMUN:QJQ
|
DK |
|
M
|
Molson Coors Beverage Co
DUS:NY7
|
US |
|
C
|
Carabao Group PCL
SET:CBG
|
TH |
|
C
|
CNH Industrial NV
XMUN:37C
|
UK |
|
B
|
Basf Se
SWB:BASA
|
DE |
|
Continental AG
F:CONA
|
DE |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
F:AIL
|
FR |
|
C
|
CombinedX AB (publ)
F:K13
|
SE |
|
Man Wah Holdings Ltd
F:AAM
|
HK |
Wall St Price Targets
RV41 Price Targets Summary
Fennec Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RV41 is 11.28 EUR with a low forecast of 10.11 EUR and a high forecast of 13.14 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV41's stock price target?
Price Target
11.28
EUR
According to Wall Street analysts, the average 1-year price target for RV41 is 11.28 EUR with a low forecast of 10.11 EUR and a high forecast of 13.14 EUR.
What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Revenue over the next 8 years is 24%.
What is the Gross Profit forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 8 years is 24%.
